Mutations of the small heterodimer partner (SHP) gene have been associated with mild obesity in Japanese subjects. This study was designed to investigate whether there was a similar association in 772 Chinese adults. A total of 272 subjects were normal weight, 423 were overweight and 77 were obese. Four non-synonymous mutations (R34X, H53fsdel10, G171A, G189E) were identified in 10 out of the 500 overweight/obese subjects, but were not seen in the normal weight controls (prevalence 2.00% versus 0.00%, respectively). The relatives of proband carriers, including 25 carriers and 33 noncarriers from three generations, were also screened for 10 multigenerational nonconsanguineous pedigrees. A genderdependent penetrance effect was observed in the pedigrees. Furthermore, the frequency of SHP gene mutations was significantly higher in those with type 2 diabetes compared with the non-diabetics (61.5% versus 28.1%, respectively). These data provide evidence of a genderdependent effect on penetrance for SHP deficiency and suggest that SHP mutations increase susceptibility to type 2 diabetes.
Gender-dependent Penetrance of Small Heterodimer Partner (SHP) Gene Deficiency in Overweight/Obese Chinese Pedigrees

Introduction
The human small heterodimer partner (SHP) gene on chromosome 1p36.1 encodes the SHP protein consisting of 257 amino acids, which is a member of the nuclear receptor family and is mainly expressed in the liver, pancreas and adipose tissue in humans. 1 Independent studies have identified many SHP target genes, reflecting the potential of SHP to regulate multiple metabolic pathways. 2 Several loss-of-function mutations in the SHP gene have been shown to co-segregate with an inherited form of early-onset mild obesity among Japanese subjects (obesity defined as a body mass index [BMI] > 25 kg/m 2 ). 3 The researchers speculated that SHP gene mutations are a component of the genetic background of obesity in the Japanese population. 3 Based on these findings in Japanese subjects, we speculated that SHP gene mutations might constitute the same common monogenic cause of adult obesity in the Chinese population. To verify this hypothesis and to establish whether this result could be replicated, the SHP genes from normal weight, overweight and obese Chinese subjects were sequenced and analysed for the presence of SHP mutations.
Subjects and methods
STUDY POPULATION
The study sample comprised individuals that were recruited mainly from the Shanghai Diabetes Institute (Shanghai, China) and also from several collaborative hospitals in China between April 2000 and July 2003. In brief, all participants attended a clinical examination that included standard anthropometric measurements and an oral glucose tolerance test. The BMI was calculated as weight in kilograms divided by the square of the height in meters (kg/m 2 ). Fasting blood samples were drawn for the measurement of serum lipids, glucose and insulin after a 10-h overnight fast. Using the homeostasis model assessment (HOMA), the insulin resistance index (HOMA-IR) was calculated as (fasting insulin [mU/l] × fasting plasma glucose [FPG; mmol/l])/22.5; and βcell function (HOMA-β) was calculated as fasting insulin × 20/(FPG -3.5). Normal weight, overweight and obese subjects were defined as having BMIs of < 25 kg/m 2 , ≥ 25 and < 30 kg/m 2 , and ≥ 30 kg/m 2 , respectively, and type 2 diabetes was diagnosed, according to World Health Organization (WHO, 1998) criteria. 4 Written and verbal informed consent was obtained from each participating subject. The study was approved by the Clinical Research Ethics Committee of Shanghai Jiaotong University (Shanghai, China).
SEQUENCE ANALYSIS OF THE SHP GENE
Genomic DNA was obtained from peripheral white blood cells using the conventional phenol/chloroform method. The exons and flanking regions of the human SHP gene (GenBank ® Accession No. AB058644) were screened by direct sequencing of the amplified polymerase chain reaction (PCR) products from the study subjects. The four sets of primer pairs used in this study to amplify the SHP gene have been described previously. 5 The PCR amplification was carried out using a 96-well microtitre format in a reaction volume of 20 µl containing 100 ng of genomic DNA, 1× PCR buffer, 0.2 µmol/l of each primer, 0.2 mmol/l of deoxynucleotide triphosphate, 1.5 mmol/l magnesium chloride and 0.4 U AmpliTaq ® DNA polymerase (Perkin-Elmer, Foster City, CA, USA) on a GeneAmp ® PCR System 9700 (Perkin-Elmer). The cycling programme involved preliminary denaturation at 95°C for 5 min, followed by 30 cycles of denaturation at 95°C for 30 s, annealing at 55°C for 30 s and elongation at 72°C for 30 s, followed by a final elongation step at 72°C for 10 min. The PCR products were purified using a PCR purification kit (Axygen Scientific, Union City, CA, USA) before being sequenced directly using specific primers with a BigDye ® Terminator version 3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA). 6 Electrophoresis was performed on an ABI PRISM ® 3100 Genetic Analyser (Applied Biosystems).
FAMILIAL STUDY
For the extension of the study to other family members, the SHP gene from available adult (≥ 18 years) relatives of the subjects in the study who were mutation carriers were also sequenced.
STATISTICAL ANALYSIS
Comparison of the mean values was done using an unpaired Student's t-test and contingency table χ 2 analysis using SPSS ® Z Yang, S Wu, T Zheng et al. SHP gene mutations in overweight/obese Chinese pedigrees version 11.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . When the sample size was < 30, the statistical significance of the difference between the groups was assessed using the Mann-Whitney U-test and the Kolmogorov-Smirnov Z-test for non-parametric results. Comparison of the prevalence of SHP gene mutations was tested with Fisher's exact test because of a theoretical sample size < 5. All reported P-values were two sided and P < 0.05 was considered to be statistically significant.
Results
STUDY POPULATION
The study sample comprised 772 individuals (459 men and 313 women) and their demographic and clinical characteristics are given in Table 1 . There were 272 normal weight subjects, 423 overweight subjects and 77 subjects classified as obese. Age, BMI, waist circumference, waist-to-hip ratio, systolic and diastolic blood pressure, and levels of triglycerides, glucose and insulin were all significantly higher in the overweight and obese subjects compared with normal weight control subjects (P < 0.001). The male:female ratio was significantly lower in the overweight and obese subjects compared with normal weight control subjects (P = 0.037).
The relatives of proband carriers, including 25 carriers and 33 non-carriers from three generations, were screened for 10 multigenerational non-consanguineous pedigrees.
DETECTION OF SHP MUTATIONS
Among the 500 overweight/obese subjects, screening resulted in the identification of four non-synonymous mutations (R34X, H53fsdel10, G171A, G189E) in 10 carriers, three of which had been previously identified 3 and one of which, G171A, had been reported as a polymorphism in a study of Caucasians. 5, 7, 8 Additionally, a new silent (synonymous) mutation, P10P, was identified in the overweight/obese group; this mutation does not lead to a change in amino acid sequence. A novel variant, IVS 1+10 C¦T, was also found in the flanking region of exon 1 in the overweight/obese group. No mutations or variants were found in the normal weight group. The mutations and variants identified in this study were all in a heterozygous state.
FUNCTIONAL CHARACTERIZATION
All of the non-synonymous mutations that were identified in this study have been demonstrated to show significantly reduced SHP functional activity in previous studies. 3, 5 
PREVALENCE OF LOSS-OF-FUNCTION SHP MUTATIONS
The prevalence of loss-of-function SHP mutations in adult overweight/obese subjects was 2.00%. The difference in the prevalence of loss-of-function mutations in the overweight/obese group compared with the control normal weight subjects was statistically significant (Fisher's exact test: 2.00% versus 0.00%, respectively; P = 0.017).
FAMILIAL PENETRANCE AND MODE OF INHERITANCE
The familial penetrance of the loss-offunction SHP mutations was evaluated for the 10 Chinese multigenerational nonconsanguineous pedigrees where the proband was overweight/obese and carried a loss-of-function SHP mutation. The familial penetrance was 64% for these heterozygous carriers ( Table 2) .
When comparing the loss-of-function SHP mutations carriers in the 10 pedigrees to their relatives with a normal SHP genotype, a significant increase in BMI of 2.38 kg/m 2 was observed (26.08 versus 23.70 kg/m 2 , respectively; P = 0.018) ( Fig. 1 ). 
Overweight or
GENDER EFFECT ON OVERWEIGHT/OBESITY PHENOTYPE IN SHP DEFICIENCY
A gender effect on BMI in the whole family sample was observed (24.76 kg/m 2 in male carriers versus 26.55 kg/m 2 in female carriers) but the difference was not statistically significant. Simultaneously, in order to investigate whether gender had an effect on penetrance for the 10 Chinese pedigrees studied, the penetrance by gender was compared. A gender-dependent penetrance effect was observed for the 10 Chinese pedigrees, with a penetrance of 82.35% in SHP-deficient female adults compared with 25.00% in SHP-deficient male adults (P = 0.010).
IDENTIFICATION OF A MUTATIONAL HOTSPOT IN EXON 1
The H53fsdel10 mutation was found in seven unrelated subjects and all of these carriers came from different geographical regions in China. The relatively high incidence of the H53fsdel10 mutation in the SHP gene reveals that there is a hotspot at codon H53.
GLUCOSE METABOLISM ABNORMALITY IN SHP DEFICIENCY
The glucose metabolism state of the carriers of the loss-of-function SHP mutations was analysed for the 10 pedigrees studied: 26 subjects had type 2 diabetes and 32 subjects did not have type 2 diabetes. It was observed that 61.5% (16/26) of the subjects with type 2 diabetes were also SHP gene mutation carriers compared with only 28.1% (9/32) of the non-diabetic subjects for the 10 pedigrees (P = 0.011; odds ratio 1.936; 95% confidence interval 1.096 -3.420).
Moreover, fasting plasma insulin levels in the loss-of-function SHP mutation carriers were higher than in subjects without the SHP mutations (28.57 versus 23.69 µU/ml, respectively; P = 0.034) for the 10 pedigrees studied. The carriers also appeared to have decreased insulin sensitivity as estimated using HOMA-IR, but the difference was not statistically significant.
Discussion
Mutations in the SHP gene have been shown to be associated with mild obesity in Japanese subjects. 3 The results were, however, controversial as subsequent studies in Caucasian populations found that mutations in the SHP gene were not cosegregated with obesity in specific pedigrees. 5, 7, 8 In the present study, the familial penetrance of a loss-of-function SHP gene mutation was only 64%. The main new finding, however, was that genderdependent penetrance existed in the 10 Chinese pedigrees studied; the penetrance in SHP-deficient female adults was significantly higher than that in SHP-deficient male adults. Furthermore, the presence of SHP mutations also increased susceptibility to type 2 diabetes in adult subjects.
The prevalence of loss-of-function SHP mutations in this series was 2.00%. Although the same recruitment criteria were used, the prevalence of loss-of-function SHP gene mutations was lower in the present study than that previously published in a Japanese cohort (6%). 3 Moreover, although the loss-offunction SHP gene mutations R34X, H53fsdel10 and G189E were previously reported to co-segregate with obesity in familial studies in Japanese subjects, these loss-of-function SHP gene mutations were not co-segregated with overweight or obese pedigrees in the present study. Given the large number of potential influences on body weight, it remains possible that more subtle mutation effects have not been identified. It would not be surprising if some genetic and environmental modifiers have some effects in some pedigrees, and such effects may explain differences in the severity of the clinical phenotype observed in different populations. Thus, the obesity phenotype associated with loss-of-function SHP mutations exhibits variable penetrance.
The present study provides the first estimates of gender-related penetrance for loss-of-function SHP mutations in Chinese pedigrees. The penetrance of male mutation carriers was significantly lower than that of female mutation carriers. The reason for this difference between genders was unclear, although hormonal status plus environmental and nutritional factors are the most likely cause of this difference. 9 In addition, twin studies have suggested that obesity may be more inheritable in females than in males. 10 Further studies are needed to elucidate the gender-dependent penetrance of SHP gene mutations in different pedigrees.
The precise mechanism underlying the effect of the SHP protein on body fat regulation has not yet been established. Studies have suggested that SHP is a nuclear receptor that interacts with a number of other nuclear receptors and inhibits their transcriptional activity. 2 Many of the reported target factors for SHP repression are implicated in regulating gene expression in pancreatic β-cells, including hepatic nuclear factor-4α (HNF-4α), 11 NeuroD 12 and Foxa2. 13 A loss of SHP function should lead to increased activity of HNF-4α, NeuroD and Foxa2, resulting in increased insulin secretion. Because insulin is one of the key hormones in adipogenesis, increased insulin secretion might promote adipogenesis. 14 Moreover, SHP also has a direct inhibitory effect on peroxisome proliferator-activated receptor-γ (PPARγ), a known stimulator of adipocyte differentiation. 15 Thus, loss of SHP activity may potentially lead to increased The finding in the present study that SHP gene mutations increase susceptibility to type 2 diabetes in adult subjects is consistent with the study by Enya et al., 16 in which SHP gene mutations were associated with later obesity and insulin resistance syndrome which, in time, may lead to diabetes. The mechanism through which SHP gene mutations increase susceptibility to type 2 diabetes remains unknown. Previous promoter microarray research has placed SHP centrally within the transcriptional circuits regulated by HNFs in human pancreatic islets, suggesting that SHP serves as an important checkpoint to balance the activity of the islet transcriptional network. 17 We postulate that loss-of-function SHP gene mutations in embryonic development should lead to increased activity of the genes that are involved in regulating pancreatic βcell differentiation and function, resulting in increased insulin secretion, leading to fetal hyperinsulinaemia and weight gain at birth and in later life. Persistent hyperinsulinaemia after birth may lead to obesity and then to secondary insulin resistance. The long-term secondary demand for compensatory insulin secretion might lead to pancreatic β-cell failure and promote the development of overt type 2 diabetes. Furthermore, the H53fsdel10 mutation was found in seven unrelated subjects in the present study. This inclusion of subjects from different geographical regions in China and the presence of three subjects with the H35fsdel10 mutation in Japanese cohorts from previous studies, 3, 16 suggest that the H35fsdel10 mutation locus is a mutational hotspot.
In summary, a gender-dependent effect on penetrance for SHP deficiency was found in obese Chinese pedigrees. It was also observed that the penetrance of male loss-of-function mutation carriers was significantly lower than that of female loss-of-function mutation carriers, suggesting that other genetic and/or environmental factors can modify the effects of SHP. Furthermore, it was demonstrated that an increased risk for type 2 diabetes was associated with SHP gene mutations. Further analysis of the functional properties of the mutant SHP proteins in glucose homeostasis should provide new insights into the development of obesity and type 2 diabetes.
